Andres Zuleta: Evaluating the RISE UP Trial Results on Mitapivat for Sickle Cell Disease
Andres Zuleta, Founder of Thrivemed, Medical Director PMC at Benchmark Hospitalists and Intensivists, shared a post on LinkedIn:
“207 people with sickle cell disease: a twice-daily pill raised hemoglobin in 41%, versus 3% on placebo.
But yearly pain crises, 2.6 vs 3.1, were not significantly different.
As a physician, I want patients to hear both results, the goal it met and the one it missed.
RISE UP (The Lancet, 2026) was a phase 3, double-blind trial at 69 sites in 15 countries.
Mitapivat activates pyruvate kinase in red cells, raising ATP and lowering 2,3-DPG, which may keep hemoglobin oxygenated longer and reduce sickling. Patients older than 16 with anemia and recurrent pain crises were randomized 2:1 to 100 mg twice daily or placebo.
What I take from it as a physician:
- Hemoglobin response (at least 1 g/dL average rise, weeks 24-52): 56 of 138 vs 2 of 69.
- Serious adverse events were 20% vs 29%; one was judged treatment related.
- Pain crises did not drop significantly, and the trial was funded by the drug’s maker, Agios.
Comment and I’ll send you the paper.
Hematologists: how much weight do you give a hemoglobin response when pain crises don’t change?”

Stay updated with Hemostasis Today.
-
Nov 19, 2026, 23:57Greta Hametner: Preventing Maternal Cardiac Complications Through Preconception Iron and Thyroid Screening
-
Nov 19, 2026, 23:49Cyrus Shariat: Why Waiting for Lab Results Can Be Fatal in HIT
-
Nov 19, 2026, 22:24Erik Nelson: Low Iron Can Raise A1c without Changing Blood Sugar
-
Nov 19, 2026, 22:23Erwin Loh: Daily Iron Supplementation Reduces Iron-Deficiency Anaemia in Children and Adolescents
-
Nov 19, 2026, 22:22Afifah Sardar: Why Can a Simple Painkiller like Aspirin Make You Bleed More?
-
Nov 19, 2026, 22:16Jonathan Penm: Perioperative Anticoagulation Management and Antithrombotic Stewardship Across 31 Countries
-
Nov 19, 2026, 22:15Salomao V.: Innovation in Hemophilia A Is Also About How Patients Receive Their Treatment
-
Nov 19, 2026, 16:27263 PolyU Students and Staff Unite to Donate Blood – Hong Kong Red Cross Blood Transfusion Service
-
Nov 19, 2026, 16:16Billy Otieno: The Future of Blood Donation Lies Beyond Collection